Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADAM17 | P78536 | 4/20 | 0.40 |
| ▸ | MMP1 | P03956 | 14/20 | 0.39 |
| ▸ | MMP13 | P45452 | 6/20 | 0.39 |
| ▸ | MMP9 | P14780 | 8/20 | 0.39 |
| ▸ | MMP3 | P08254 | 5/20 | 0.39 |
| ▸ | ANPEP | P15144 | 2/20 | 0.38 |
| ▸ | MMP2 | P08253 | 4/20 | 0.37 |
| ▸ | PDE4A | P27815 | 2/20 | 0.36 |
| ▸ | PDE4B | Q07343 | 2/20 | 0.36 |
| ▸ | PDE4C | Q08493 | 2/20 | 0.36 |
| ▸ | PDE4D | Q08499 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6940092 | 0.92 | ADAM17 (0.44) | ADAM17MMP1MMP13MMP9MMP3 | |
| SCHEMBL6943723 | 0.91 | ADAM17 (0.44) | ADAM17MMP1MMP13MMP9MMP3 | |
| SCHEMBL6947183 | 0.85 | ALDH1A1 (0.32) | MMP1MMP13MMP9MMP3MMP2 | |
| SCHEMBL6938061 | 0.85 | ADAM17 (0.40) | ADAM17MMP1MMP13MMP9MMP3 | |
| SCHEMBL6942610 | 0.85 | ADAM17 (0.46) | ADAM17MMP1MMP13MMP9MMP3 | |
| SCHEMBL6941767 | 0.85 | ADAM17 (0.46) | ADAM17MMP1MMP13MMP9MMP3 | |
| SCHEMBL4481740 | 0.85 | ADAM17 (0.46) | ADAM17MMP1MMP13MMP9MMP3 | |
| SCHEMBL8107345 | 0.84 | ADAM17 (0.41) | ADAM17MMP1MMP13MMP9MMP3 | |
| SCHEMBL6947369 | 0.84 | ADAM17 (0.42) | ADAM17MMP1MMP13MMP9MMP3 | |
| SCHEMBL6944422 | 0.84 | ADAM17 (0.44) | ADAM17MMP1MMP13MMP9MMP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0993442-B1 | HYDRAZINE DERIVATIVES | HOFFMANN LA ROCHE (CH) | 2003-04-23 | — | — | EP | disclosed |
| US-6235787-B1 | ANTIINFLAMMATORY AGENTS; RHEUMATIC DISEASES; BONE DISORDERS; SKIN DISORDERS; MULTIPLE SCLEROSIS | HOFFMANN-LA ROCHE INC. | 2001-05-22 | — | — | US | disclosed |
| EP-0993442-A1 | HYDRAZINE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2000-04-19 | — | — | EP | disclosed |
| WO-1999001428-A1 | HYDRAZINE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 1999-01-14 | — | — | WO | disclosed |